Evaluation of Medical-Grade Polycaprolactone for 3D Printing: Mechanical, Chemical, and Biodegradation Characteristics

Polycaprolactone (PCL) is one of the most widely used polymers in tissue engineering owing to its excellent biocompatibility, biodegradability, and processability. Nevertheless, most previous studies have primarily employed research-grade PCL, thereby limiting its clinical translation. In this study, four types of medical-grade PCL (RESOMER® C203, C209, C212, and C217) were systematically evaluated for their applicability in three-dimensional (3D) printing, with respect to printability, mechanical characteristics, chemical stability, and biodegradation behavior. Among these, C209 and C212 exhibited superior printability and mechanical strength. FT-IR analysis showed that the chemical structure of PCL remained unchanged after both 3D printing and E-beam sterilization, while compressive testing demonstrated no significant differences in mechanical characteristics. In vitro degradation assessment revealed a time-dependent decrease in molecular weight. For kinetic analysis, both C209 and C212 were fitted using pseudo-first-order and pseudo-second-order models, which yielded comparable coefficients of determination (R2), suggesting that degradation may be governed by multiple factors rather than a single kinetic pathway. Taken together, these findings indicate that medical-grade PCL, particularly C209 and C212, is highly suitable for 3D printing. Furthermore, this study provides fundamental insights that may facilitate the clinical translation of PCL-based scaffolds for tissue engineering and biomedical implantation.